Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 67
- Medical
MGC Pharma receives approval for COVID-19 treatment
MGC Pharmaceuticals has received a Free Trade Certificate in Germany for its product ArtemiC which has shown successful results in treating COVID-19 patients.
- Companies
Psychedelic entrepreneur Christian Angermayer acquires SynBiotic shares
Apeiron Investment Group is now the largest shareholder of European cannabis company SynBiotic.
- Uncategorized
National Underwriter to provide cannabis certifications for insurers
The certification has been launched for the needs of insurance producers, agents, risk managers, and others in cannabis business.
- Uncategorized
GPS to advance global cannabis industry with cannabis collective acquisition
Global consortium Gateway Proven Strategies has acquired the Global Cannabis Network Collective.
- Companies
Materia Malta receives licence for commercial cannabis production
Materia announced that its wholly-owned subsidiary, Materia Malta, has received the licence from the Malta Medicines Authority.
- Companies
Roth Capital to host Women Cannabis Pioneers Investor Conference
Roth Capital Partners is to host the inaugural Women Cannabis Pioneers – The Brand Builders Investor Conference.
- Medical
Landmark UK approval for THC refractory epilepsy treatment
The medicine will now be available on prescription for patients in the UK.
- CBD Market
UK CBD company Kaya raises £1.7m for European expansion
Kaya co-founder Ludovic Rachou discusses the company’s journey and plans for European expansion.
- Medical
Czech market receives Motagon’s Gorilla Glue 4 cannabis for patients
Motagon says the import is a unique medical cannabis frontier with immense potential.
- Cultivation
Guernsey receives seven applications for high-THC cultivation licences
Guernsey says that the majority of the applications received so far aim to produce cannabis-based medicinal products.
- Medical
Small scale cannabis cultivation set to be decriminalised in Italy
Italy could join Austria and Cyprus as one of the only countries to allow home cultivation for medicinal use.
- Companies
Panaxia to exit cannabis activities in Israel and focus on Europe
The company is looking forward to beginning products sales designed for the Oncology field in partnership with the German company, Axio-Novo, this year.
